According to a new market report published by Lucintel, the future of the next generation sequencing market looks promising with opportunities in academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The global next generation sequencing market is expected to grow with a CAGR of 21% from 2021 to 2026. The major drivers for this market are government regulations and reimbursement for NGS-based diagnostic tests, advancements in NGS platforms, and declining costs of NGS tests.
To download report brochure, please go to https://www.lucintel.com/next-generation-sequencing-market.aspx and click "download brochure" tab from the menu.
In this market, next generation sequencing are used in various applications, such as diagnostics, drug discovery, and agriculture & animal research. Diagnostic application will remain the largest segment due to rising number of cancer cases across the world.
Within the next generation sequencing market, academic institutes & research centers will remain the largest end user segment during the forecast period due to the development of cost-effective NGS products and services for researchers and increasing collaborations between academic institutes & research centers and NGS players.
North America will remain the largest region during the forecast period due to the investments in research funding, and development of NGS data analysis solutions.
Illumina, Inc., Thermo Fisher Scientific, Inc. BGI Group, PerkinElmer Inc., Macrogen, Hamilton Company, Lucigen, Oxford Nanopore Technologies, Agilent Technologies, Inc., and QIAGEN are among the major next generation sequencing manufacturers.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global next generation sequencing market by product & service, technology, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Next Generation Sequencing Market 2021-2026: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global next generation sequencing market by product & service, technology, application, end user, and region as follows:
By Product & Service [$M shipment analysis for 2015 – 2026]:
Presequencing Products & Services
NGS consumables
NGS Platforms
Services for NGS Platforms
Sequencing Services
Bioinformatics
By Technology [$M shipment analysis for 2015 – 2026]
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Other Sequencing Technologies
By Application [$M shipment analysis for 2015 – 2026]:
Diagnostics
Drug Discovery
Agriculture & Animal Research
Other Applications
By End User [$M shipment analysis for 2015 – 2026]:
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
By Region [$M shipment analysis for 2015 – 2026]:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Asia Pacific
China
Japan
India
South Korea
The Rest of the World
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. We offer market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.